Discounted Cash Flow Rating

Buy

Return on Equity Rating

Neutral

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Sell

Analyst Rating

Buy

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Buy

A

Smith & Nephew plc (SNN)

https://www.smith-nephew.com

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/16/1999

Market Cap

13,175,164,500

Shares Outstanding

874,230,000

Weighted SO

437,115,838

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

CHEOY --.--%

ITGR --.--%

CFMS --.--%

MOTS --.--%

OFIX --.--%

NUVA --.--%

GKOS --.--%

HSKA --.--%

BRKR --.--%

Beta

0.6000

Last Div

0.7500

Range

21.53-31.13

Chg

0.1300

Avg Vol

808103

Mkt Cap

13175164500

Exch

NYSE

Country

GB

Phone

44 1923 477 100

DCF Diff

10.7378

DCF

19.3872

Div Yield

0.0248

P/S

2.3445

EV Multiple

10.9556

P/FV

2.5310

Div Yield %

2.4818

P/E

43.2961

PEG

18.2090

Payout

1.0694

Current Ratio

2.5087

Quick Ratio

1.1069

Cash Ratio

0.3196

DSO

90.8663

DIO

522.5687

Op Cycle

613.4349

DPO

214.8175

CCC

398.6175

Gross Margin

0.6904

Op Margin

0.1474

Pretax Margin

0.0611

Net Margin

0.0541

Eff Tax Rate

0.0789

ROA

0.0289

ROE

0.0584

ROCE

0.0945

NI/EBT

0.8863

EBT/EBIT

0.4144

EBIT/Rev

0.1474

Debt Ratio

0.3342

D/E

0.6768

LT Debt/Cap

0.3765

Total Debt/Cap

0.4036

Int Coverage

5.2304

CF/Debt

0.2067

Equity Multi

2.0254

Rec Turnover

4.0169

Pay Turnover

1.6991

Inv Turnover

0.6985

FA Turnover

3.8998

Asset Turnover

0.5331

OCF/Share

1.6704

FCF/Share

0.6872

Cash/Share

1.3029

OCF/Sales

0.1296

FCF/OCF

0.4114

CF Coverage

0.2067

ST Coverage

1.9162

CapEx Coverage

1.6989

Div&CapEx Cov

0.9657

P/BV

2.5310

P/B

2.5310

P/S

2.3445

P/E

43.2961

P/FCF

43.9815

P/OCF

18.0920

P/CF

18.0920

PEG

18.2090

P/S

2.3445

EV Multiple

10.9556

P/FV

2.5310

DPS

0.7500

Latest Headlines (EST)

GlobeNewswire Inc. May 18, 23:30 Impregnated Foam Dressing Market Trends, Opportunities and Forecast 2025–2034 | Exactitude Consultancy GlobeNewswire Inc. Apr 10, 05:30 Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights GlobeNewswire Inc. Jan 24, 00:30 Hip and Knee Reconstructive Market to Reach USD 41,071.4 Million by 2035, Growing at a 5.6% CAGR from 2025 to 2035 | FMI GlobeNewswire Inc. Oct 16, 04:00 Hyaluronic Acid Market Driven by Increasing Demand for Cosmetics and Expected to Grow over 21 Bn by 2032 GlobeNewswire Inc. Jan 14, 16:00 Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report GlobeNewswire Inc. Jan 14, 16:00 Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report GlobeNewswire Inc. Jan 14, 16:00 Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report GlobeNewswire Inc. Jan 14, 16:00 Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report GlobeNewswire Inc. Jan 14, 16:00 Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report GlobeNewswire Inc. Jan 14, 16:00 Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report GlobeNewswire Inc. Jan 14, 16:00 Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report GlobeNewswire Inc. Jan 14, 16:00 Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report GlobeNewswire Inc. Jan 14, 16:00 Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report GlobeNewswire Inc. Jan 14, 16:00 Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report GlobeNewswire Inc. Jan 14, 16:00 Australia’s approach to musculoskeletal injury care and reimbursement demands rethink: Report

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.46 04/01/2024 03/04/2024 04/02/2024 05/22/2024
0.29 10/05/2023 08/03/2023 10/06/2023 11/01/2023
0.46 03/30/2023 02/27/2023 03/31/2023 05/17/2023
0.28 09/29/2022 08/01/2022 09/30/2022 10/26/2022
0.45 03/31/2022 03/14/2022 04/01/2022 05/11/2022
0.28 09/30/2021 08/13/2021 10/01/2021 10/27/2021
0.46 04/05/2021 02/22/2021 04/06/2021 05/12/2021
0.28 10/01/2020 07/29/2020 10/02/2020 10/28/2020
0.46 04/02/2020 02/24/2020 04/03/2020 05/06/2020
0.29 10/03/2019 09/23/2019 10/04/2019 10/30/2019
0.44 04/04/2019 02/15/2019 04/05/2019 05/08/2019
0.28 10/04/2018 11/30/-0001 10/05/2018 10/31/2018
0.45 04/05/2018 02/08/2018 04/06/2017 05/09/2018
0.25 10/05/2017 08/28/2017 10/06/2017 11/01/2017
0.37 03/29/2017 02/27/2017 03/31/2017 05/10/2017
0.25 10/05/2016 09/01/2016 10/07/2016 10/25/2016
0.38 04/20/2016 02/08/2016 04/22/2016 05/11/2016
0.24 10/07/2015 08/31/2015 11/30/-0001 10/27/2015
0.37 04/15/2015 04/17/2015 04/17/2015 05/06/2015
0.22 10/22/2014 10/14/2014 10/24/2014 11/11/2014
0.85 04/17/2014 02/19/2014 04/22/2014 05/07/2014
0.52 10/09/2013 08/27/2013 10/11/2013 10/29/2013
0.81 04/17/2013 03/08/2013 04/19/2013 05/08/2013
0.50 10/10/2012 09/21/2012 11/30/-0001 10/30/2012
0.54 04/18/2012 02/08/2012 11/30/-0001 05/09/2012
0.33 10/12/2011 09/01/2011 11/30/-0001 11/01/2011
0.49 04/29/2011 02/18/2011 11/30/-0001 05/19/2011
0.30 10/13/2010 08/09/2010 11/30/-0001 11/02/2010
0.45 04/21/2010 11/30/-0001 11/30/-0001 11/30/-0001
0.27 10/14/2009 09/24/2009 11/30/-0001 11/03/2009
0.41 04/15/2009 03/03/2009 11/30/-0001 05/08/2009
0.25 10/15/2008 11/30/-0001 11/30/-0001 11/30/-0001
0.37 04/16/2008 11/30/-0001 11/30/-0001 11/30/-0001
0.23 10/17/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.33 04/18/2007 11/30/-0001 11/30/-0001 11/30/-0001
0.20 10/18/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.30 04/19/2006 11/30/-0001 11/30/-0001 11/30/-0001
0.19 10/19/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.30 04/20/2005 11/30/-0001 11/30/-0001 11/30/-0001
0.17 10/20/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.29 04/21/2004 11/30/-0001 11/30/-0001 11/30/-0001
0.30 08/13/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.54 04/17/2003 11/30/-0001 11/30/-0001 11/30/-0001
0.31 10/16/2002 11/30/-0001 11/30/-0001 11/30/-0001
0.46 04/17/2002 11/30/-0001 11/30/-0001 11/30/-0001
0.28 11/07/2001 11/30/-0001 11/30/-0001 11/30/-0001
0.45 04/18/2001 11/30/-0001 11/30/-0001 11/30/-0001
0.28 11/08/2000 11/30/-0001 11/30/-0001 11/30/-0001
0.57 05/04/2000 11/30/-0001 11/30/-0001 11/30/-0001